Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity
Jie Yin(Hunan Agricultural University), Xi Wang(European Molecular Biology Organization), Qi Luo(Institute of High Energy Physics), Huafeng Xie(Boston Children's Hospital), Junwei Hao(Capital Medical University), Harvey Cantor(Harvard University), Liyun Y. Zhang(Tianjin University of Traditional Chinese Medicine), Charles W.M. Roberts(Harvard University), Jianmei W. Leavenworth(University of Alabama at Birmingham), Shan Huang(Wuhan University), Yang Li(Institute of Applied Physics), Xinhua Liu(Fujian Medical University), Zheng Fu(Wuhan University), Litao Zhang(Tianjin University of Traditional Chinese Medicine), Stuart H. Orkin(Brigham and Women's Hospital), Xudong Wu(Tianjin Medical University General Hospital), Han Yan(Tianjin Medical University), Xianming Deng(Xiamen University)
Cited by 168
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
Toward understanding and exploiting tumor heterogeneity
|Nature Medicine|2015|770
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
|Cancer Discovery|2016|632